| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $750.6M | — | +1.3% |
| Cost of Revenue | $398.3M | — | +1.9% |
| R&D Expense | $41.4M | — | +3.0% |
| SG&A Expense | $159.0M | — | -0.8% |
| Operating Income | $134.8M | — | +3.6% |
| Pre-tax Income | $121.1M | — | +9.0% |
| Income Tax | $26.8M | — | +15.5% |
| Net Income | $94.3M | — | +7.3% |
| EPS (Basic) | $0.67 | — | +13.6% |
| EPS (Diluted) | $0.66 | — | +11.9% |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $233.8M | -52.5% | -29.9% |
| Accounts Receivable | $529.6M | +0.4% | -0.7% |
| Inventory | $341.5M | +4.6% | -4.1% |
| Current Assets | $1.27B | -15.1% | -7.5% |
| Total Assets | $4.13B | -5.4% | -3.8% |
| Current Liabilities | $1.03B | -20.0% |
| Line Item | 2026-04-03 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $46.5M | — | -57.9% |
| Capital Expenditures | $21.7M | — | +22.6% |
| Investing Cash Flow | -$21.0M | — | -18.6% |
| Financing Cash Flow | -$281.2M | — | -134.9% |
| Free Cash Flow | $24.8M | — | -73.2% |
| +22.3% |
| Long-term Debt | $1.59B | +0.0% | -23.8% |
| Total Liabilities | $2.87B | -8.1% | -10.1% |
| Stockholders' Equity | $1.26B | +1.2% | +14.9% |